The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: a retrospective study-Reference-Cited by-同舟云学术

The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: a retrospective study

Published:2022-02-21 Issue:5 Volume:101 Page:1049-1057
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Baysal Mehmet^ORCID,Gürsoy Vildan,Hunutlu Fazil Cagri,Erkan Buket,Demirci Ufuk,Bas Volkan,Gulsaran Sedanur Karaman,Pinar Ibrahim Ethem,Ersal Tuba,Kirkizlar Tugcan Alp,Atli Emine Ikbal,Kirkizlar Hakki Onur,Ümit Elif G,Gürkan Hakan,Ozkocaman Vildan,Ozkalemkas Fahir,Demir Ahmet Muzaffer,Ali Ridvan

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00277-022-04798-8.pdf

Reference51 articles.

1. Hillestad LK (1957) Acute promyelocytic leukemia. Acta med Scand 159(3):189–194

2. Rowley JD, Golomb HM, Dougherty C (1977) 15/17 translocation, a consistent chromosomal change in acute promyelocytic leukemia. Lancet 1(8010):549–550

3. Larson RA, Kondo K, Vardiman JW, Butler AE, Golomb HM, Rowley JD et al (1984) Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia. Am J Med 76(5):827–841

4. Grimwade D, Howe K, Langabeer S, Davies L, Oliver F, Walker H et al (1996) Establishing the presence of the t(15;17) in suspected acute promyelocytic leukemia: cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the M.R.C. ATRA trial. M.R.C. Adult Leukaemia Working Party. Br J Haematol 94(3):557–573

5. Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L et al (1988) Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72(2):567–572

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 20(S)-ginsenoside Rh2 ameliorates ATRA resistance in APL by modulating lactylation-driven METTL3;Journal of Ginseng Research;2023-12

2. Does leukocytosis remain a predictive factor for survival outcomes in patients with acute promyelocytic leukemia receiving ATRA plus a chemotherapy-based regimen? A prospective multicenter analysis from TALWG;Hematology;2023-03-23